June 21, 2022
Medwatcher Japan, a citizen’s drug damage watchdog, issued a statement on June 20 opposing the proposed application of the newly introduced emergency approval system to Shionogi’s COVID-19 pill ensitrelvir, saying that the medicine does not meet the “presumed efficacy” criteria...read more